Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on... 
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and
...
|
More...
Dow AgroSciences, KWS Enter Into Agreement for Research & Product Development
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that it has entered into a long-term research and product development
...
|
More...
University, government and philanthropic leaders converge in Seattle to advance global health
'Transforming Global Health: The Interdisciplinary Power of Universities' is the theme of the Consortium of Universities for Global Health Conference More than 600 people will
...
|
More...
Ortho-McNeil-Janssen Taps Anchor for Pepducin Technology
Deal includes Anchor’s preclinical gpr39-targeting program and $480 million in milestones. [© lily - Fotolia.com] KEYWORDS: , , , , (Page 1 of 1)
...
|
More...
Hospira and Smiths Medical to Co-Promote Infusion Pumps and Develop a Standardized Safety...
Hospira, Inc. (NYSE: HSP), a leading provider of clinical information and medication delivery technologies, and Smiths Medical, a leading global medical device manufacturer, today
...
|
More...
David Irby and Richard Reznick are awarded prize in medical education research
Professors David M. Irby and Richard K. Reznick are awarded the 2010 Karolinska Institutet Prize for Research in Medical Education.
|
More...
University of Liverpool and ISAEC to research genetics of drug-induced hypersensitivity...
The University of Liverpool to coordinate an international research network to research the role of genetic variation in drug-induced hypersensitivity reactions Chicago
...
|
More...
Newcastle University and ISAEC to research genetics of drug induced liver injury
Newcastle to coordinate an international research network to research the role of genetic variation in drug induced liver injury Chicago (September 9, 2010) ? The International
...
|
More...
Neurokine Announces Formation of Scientific and Clinical Advisory Board
Neurokine Pharmaceuticals Inc. (OTCBB: NEUKF) is pleased to announce that Dr. Patrick McGeer has joined its newly formed Scientific and Clinical Advisory Board.
|
More...
Research!America asks Congress to support embryonic stem cell research now
August poll: 70 percent of public support expanded federal stem cell research funding WASHINGTON?September 8, 2010?Research!America today called on Congress to take legislative
...
|
More...
